Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study
Primary Purpose
Seizure, Alcohol Related
Status
Withdrawn
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
levetiracetam
Sponsored by
About this trial
This is an interventional treatment trial for Seizure, Alcohol Related focused on measuring Alcohol seizure
Eligibility Criteria
Inclusion Criteria:
- No trauma
- Not pregnant
- No other cause for seizure (hypoglycemia, CNS causes, trauma)
- Good family support
- Working telephone contact
Exclusion Criteria:
- Pregnancy
- Renal failure (creatine > 2mg/dl
- Fever or illness
- Hypotension
- Any trauma
Sites / Locations
- Medical University of South Carolina
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
1
Arm Description
Outcomes
Primary Outcome Measures
Decreased seizures
Secondary Outcome Measures
Full Information
NCT ID
NCT00627133
First Posted
February 20, 2008
Last Updated
June 5, 2018
Sponsor
Medical University of South Carolina
Collaborators
UCB Pharma
1. Study Identification
Unique Protocol Identification Number
NCT00627133
Brief Title
Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study
Official Title
A Pilot Study Examining the Efficacy of Keppra in Acute Alcohol Related Seizure Control in the Emergency Department Setting
Study Type
Interventional
2. Study Status
Record Verification Date
February 2008
Overall Recruitment Status
Withdrawn
Study Start Date
February 2008 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medical University of South Carolina
Collaborators
UCB Pharma
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Seizure, Alcohol Related
Keywords
Alcohol seizure
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
levetiracetam
Intervention Description
2 gram iv load, 500mg bid
Primary Outcome Measure Information:
Title
Decreased seizures
Time Frame
1, 2, 4, 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
No trauma
Not pregnant
No other cause for seizure (hypoglycemia, CNS causes, trauma)
Good family support
Working telephone contact
Exclusion Criteria:
Pregnancy
Renal failure (creatine > 2mg/dl
Fever or illness
Hypotension
Any trauma
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study
We'll reach out to this number within 24 hrs